相似文献
1
Dyshydrotic Eczema Secondary to Intravenous Immunoglobulin Infusion: A Report of 2 Cases.
Actas Dermosifiliogr. 2016 Jun;107(5):431-3. doi: 10.1016/j.ad.2015.09.018. Epub 2016 Jan 5.
2
Pompholyx after intravenous immunoglobulin therapy for treatment of Guillain-Barré syndrome.
J Eur Acad Dermatol Venereol. 2009 May;23(5):602-4. doi: 10.1111/j.1468-3083.2008.02980.x. Epub 2008 Aug 29.
3
Severe dyshidrotic eczema after intravenous immunoglobulin therapy for Kawasaki syndrome.
Pediatr Dermatol. 2013 May-Jun;30(3):e30-1. doi: 10.1111/j.1525-1470.2011.01717.x. Epub 2012 Feb 3.
4
Dyshidrotic-like spongiotic dermatitis after intravenous immunoglobulin therapy.
J Drugs Dermatol. 2003 Jun;2(3):337-41.
5
Dyshidrotic eczema following intravenous immunoglobulin treatment.
CMAJ. 2013 Aug 6;185(11):E530. doi: 10.1503/cmaj.121036. Epub 2012 Dec 3.
6
Late-onset and long-term systemic dyshidrotic eczema after intravenous immunoglobulin treatment for Kawasaki disease.
BMJ Case Rep. 2019 Mar 21;12(3):e229596. doi: 10.1136/bcr-2019-229596.
7
Pompholyx (vesicular eczema) after i.v. immunoglobulin therapy for neurologic disease.
Neurology. 1999 Sep 22;53(5):1154-5. doi: 10.1212/wnl.53.5.1154.
8
Pompholyx induced by intravenous immunoglobulin therapy.
J Investig Allergol Clin Immunol. 2007;17(4):277-8.
9
Dyshidrotic eczema and seborrheic dermatitis-like eczematous eruption following intravenous immunoglobulin therapy.
Dermatol Ther. 2020 Nov;33(6):e14147. doi: 10.1111/dth.14147. Epub 2020 Sep 3.
10
Vesicular eczema after intravenous immunoglobulin therapy for treatment of Stevens-Johnson syndrome.
Arch Dermatol. 2006 Feb;142(2):247-8. doi: 10.1001/archderm.142.2.247.
引用本文的文献
1
Late-onset and long-term systemic dyshidrotic eczema after intravenous immunoglobulin treatment for Kawasaki disease.
BMJ Case Rep. 2019 Mar 21;12(3):e229596. doi: 10.1136/bcr-2019-229596.
Zotero 插件